COMP <GO>
LONA vs TIL // EV/EBITDA & P/E VALUATION
LeonaBio Inc. (NASDAQ) VS. Instil Bio Inc. (NASDAQ) • 15-METRIC TALLY: LONA 0
— TIL 3
■ METRIC PARITY
LAST: $4.91 (-1.01%) • MKT CAP: $46.3M
valuation
—
LAST: $6.83 (+0.52%) • MKT CAP: $46.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LONA VS. TIL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LONA | TIL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | TIL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.7 | 56.4 | -12.65 | TIL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.3M | $46.3M | -$26.6K | TIL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LONA REV | TIL REV | LONA GROSS % | TIL GROSS % | LONA FCF | TIL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$45.7M | -$36.6M |
| FY 2024 | $0 | $0 | — | — | -$97.2M | -$55.7M |
| FY 2023 | $0 | $0 | — | — | -$100.8M | -$82.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LONA // BETA —
TIL // BETA —